World Health Organization. (2019). WHO Classification of Tumours of the Digestive System. 5th Edition. IARC Press, Lyon.
[2]
European Study Group on Cystic Tumours of the Pancreas. (2018). European evidence-based guidelines on pancreatic cystic neoplasms. Gut, 67(5), 789-804.
[3]
American Gastroenterological Association. (2015). Guidelines on the management of pancreatic cysts. Gastroenterology, 148(4), 819-822.
[4]
Tanaka, M., et al. (2017). International consensus guidelines 2017 for management of IPMN and MCN of the pancreas. Pancreatology, 17(5), 739-767.
Basturk, O., et al. (2015). The spectrum of pancreatitis-associated cystic neoplasms. Archives of Pathology & Laboratory Medicine, 139(7), 882-890.
[7]
Sarr, M. G., et al. (2013). Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or invasive) cystic neoplasms? Annals of Surgery, 258(3), 466-475.
[8]
Jang, J. W., et al. (2014). Long-term outcomes and recurrence patterns of serous cystic neoplasm of the pancreas. Journal of Korean Medical Science, 29(3), 392-398.
Reid, M. D., et al. (2016). Cystic lesions of the pancreas: differential diagnosis and cytologic-histologic correlation. Journal of American Society of Cytopathology, 5(4), 215-229.